Cui Xiangmin
- SEC CIK
- 0001487815
In the past year, 6 open-market sale filings worth $564.4K and no purchases.
Current role at each company
- NUVB Nuvation Bio Inc.Directoras of May 26, 2026
- BYSI BeyondSpring Inc.10% Owneras of Oct 20, 2025
- AARD Aardvark Therapeutics, Inc.10% Owneras of Feb 19, 2025
- ALPN Alpine Immune Sciences, Inc.Director, 10% Owneras of May 20, 2024
- CGON CG Oncology, Inc.10% Owneras of Apr 9, 2024
Show 1 more company
- HLTH Cue Health Inc.Directoras of Sep 30, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $564.4K
- 6 filings
- Net
- −$564.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cui Xiangmin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BYSI BeyondSpring Inc.
10% Owner17 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 (view filing)8:00 PM ET | Oct 16-17 | 4 days | Cui Xiangmin and 6 others10% Owner | SSale | −131.3K | $1.73 | −$227.7K | −8.0%1.52M after | 2 lots |
| Oct 15, 2025 (view filing)8:07 PM ET | Oct 13-15 | 2 days | Cui Xiangmin and 6 others10% Owner | SSale | −153.8K | $1.68 | −$259.2K | −8.5%1.65M after | 3 lots |
| Oct 10, 2025 (view filing)5:58 PM ET | Oct 8-10 | 2 days | Cui Xiangmin and 6 others10% Owner | SSale | −13.9K | $1.78 | −$24.7K | −0.8%1.80M after | 3 lots |
| Oct 7, 2025 (view filing)6:14 PM ET | Oct 3-7 | 4 days | Cui Xiangmin and 6 others10% Owner | SSale | −20.2K | $1.78 | −$36.0K | −1.1%1.82M after | 3 lots |
| Oct 2, 2025 (view filing)8:51 PM ET | Sep 30-Oct 2 | 2 days | Cui Xiangmin and 6 others10% Owner | SSale | −7.67K | $1.80 | −$13.8K | −0.4%1.84M after | 3 lots |
| Sep 29, 2025 (view filing)8:06 PM ET | Sep 25-29 | 4 days | Cui Xiangmin and 5 others10% Owner | SSale | −1.80K | $1.69 | −$3.04K | −0.1%1.85M after | 3 lots |
| Sep 24, 2025 (view filing)6:49 PM ET | Sep 22-24 | 2 days | Cui Xiangmin and 5 others10% Owner | SSale | −11.8K | $1.76 | −$20.8K | −0.6%1.85M after | 3 lots |
| Sep 19, 2025 (view filing)6:03 PM ET | Sep 17-19 | 2 days | Cui Xiangmin and 5 others10% Owner | SSale | −11.3K | $1.77 | −$20.0K | −0.6%1.86M after | 3 lots |
| Sep 16, 2025 (view filing)7:45 PM ET | Sep 12-16 | 4 days | Cui Xiangmin and 5 others10% Owner | SSale | −4.11K | $1.85 | −$7.60K | −0.2%1.87M after | 3 lots |
| Sep 11, 2025 (view filing)7:43 PM ET | Sep 9-11 | 2 days | Cui Xiangmin and 5 others10% Owner | SSale | −21.0K | $1.94 | −$40.9K | −1.1%1.87M after | 3 lots |
AARD Aardvark Therapeutics, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2025 (view filing)5:44 PM ET | Feb 14 | 5 days | Cui Xiangmin and 4 others10% Owner | PPurchase | +1.25M | $16.00 | +$20.0M | New position958.4K after | 2 lots |
NUVB Nuvation Bio Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2024 (view filing) | Jun 25 | 1 day | Cui XiangminDirector | PPurchaseClass A Common Stock | +277.9K | $2.97 | +$825.3K | +12.8%2.45M after | |
| Jun 25, 2024 (view filing) | Jun 20-24 | 5 daysLate | Cui XiangminDirector | PPurchaseClass A Common Stock | +500.0K | $2.98 | +$1.49M | +29.8%2.18M after | 3 lots |
CGON CG Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2024 (view filing)7:08 PM ET | Jan 29 | 71 days | Cui Xiangmin and 4 others10% Owner | PPurchase | +400.0K | $19.00 | +$7.60M | +8.8%4.96M after | Amended |
ALPN Alpine Immune Sciences, Inc.
Director, 10% Owner2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 (view filing) | Nov 9 | 5 days | Cui XiangminDirector, 10% Owner | PPurchase | +375.0K | $12.50 | +$4.69M | +27.6%1.74M after | |
| Sep 21, 2021 (view filing) | Sep 17 | 4 days | Cui XiangminDirector, 10% Owner | PPurchase | +1.54M | $9.40 | +$14.5M | +48.7%4.71M after |